1558 — Yichang Hec Changjiang Pharmaceutical Co Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- HK$13.97bn
- HK$14.88bn
- CNY3.72bn
Brief: YiChang HEC Changjiang Pharmaceutical Says NMPA Approves Launch Of Duloxetine Hydrochloride Enteric Capsules
Brief: Yichang Hec Changjiang Pharmaceutical Co Says Emitasvir Phosphate Capsules Approved To Launch By Nmpa
Brief: Yichang Hec Changjiang Pharma Says Alogliptin Benzoate Tablets Of Dongguan Yangzhikang Pharma Obtained NMPA Approval
Brief: Yichang Hec Changjiang Pharmaceutical Says Rosuvastatin Calcium Tablets Got Launch Approval From NMPA
Brief: Yichang Hec Changjiang Pharmaceutical Says Tadalafil Tablets Got Approval For Launch
Brief: YiChang HEC Changjiang Pharmaceutical Says Ticagrelor Tablets Approved To Launch
Brief: Yichang Hec Changjiang Pharmaceutical Says 9-Mnth Profit & Total Comprehensive Income Attributable Drops
Brief: Yichang Hec Changjiang Pharma Gets Approval For Registration For Domestic Production Of Insulin Glargine Injection
Brief: Yichang Hec Changjiang Pharmaceutical Says Co Informed That Guangdong HEC Technology Holding Co. Acquired H Shares Of Co
Brief: Yichang Hec Changjiang Pharmaceutical Says Co Participated In Tender Process For Third National Centralized Procurement Of Pharmaceuticals
Brief: Yichang Hec Changjiang Pharma Enters LOI For National Collaborative Innovation Industrialization Platform
Brief: Yichang Hec Changjiang Pharmaceutical Recommends Interim Dividend
Brief: Yichang Hec Changjiang Pharmaceutical Says Unit Enters Construction Work Contract
Brief: Yichang Hec Changjiang Pharmaceutical Sees HY Profit Attributable Decrease By About 35%-45%
Brief: Yichang Hec Changjiang Pharmaceutical Says Linagliptin Tablets Approval To Launch
Brief: Yichang Hec Changjiang Pharmaceutical Gets Approval For Listing Of 213.8 Million Bonus H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Recombinant Human Insulin Injection Got Launch Approval
HK-listed pharmaceutical product maker YiChang hit 6-week high on drug update
Brief: Yichang Hec Changjiang Pharma Got CSRC Approval For Full Circulation Of H Shares